These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9735392)

  • 1. Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein.
    Basu A; Haldar S
    Int J Oncol; 1998 Oct; 13(4):659-64. PubMed ID: 9735392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
    Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
    Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells.
    Haldar S; Basu A; Croce CM
    Cancer Res; 1998 Apr; 58(8):1609-15. PubMed ID: 9563469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
    Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T
    Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl2 is the guardian of microtubule integrity.
    Haldar S; Basu A; Croce CM
    Cancer Res; 1997 Jan; 57(2):229-33. PubMed ID: 9000560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1.
    Pathan N; Aime-Sempe C; Kitada S; Basu A; Haldar S; Reed JC
    Neoplasia; 2001; 3(6):550-9. PubMed ID: 11774038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxol mediates serine phosphorylation of the 66-kDa Shc isoform.
    Yang CP; Horwitz SB
    Cancer Res; 2000 Sep; 60(18):5171-8. PubMed ID: 11016645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Taxol-induced cell death are concentration dependent.
    Torres K; Horwitz SB
    Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase.
    Srivastava RK; Srivastava AR; Korsmeyer SJ; Nesterova M; Cho-Chung YS; Longo DL
    Mol Cell Biol; 1998 Jun; 18(6):3509-17. PubMed ID: 9584191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxol can induce phosphorylation of BCL-2 in multiple myeloma cells and potentiate dexamethasone-induced apoptosis.
    Kroning R; Lichtenstein A
    Leuk Res; 1998 Mar; 22(3):275-86. PubMed ID: 9619919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
    Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ
    Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1.
    Pathan N; Aime-Sempe C; Kitada S; Haldar S; Reed JC
    Neoplasia; 2001; 3(1):70-9. PubMed ID: 11326318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interaction between topotecan and microtubule-interfering agents.
    Bahadori HR; Green MR; Catapano CV
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):188-96. PubMed ID: 11592339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
    Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
    Ibrado AM; Liu L; Bhalla K
    Cancer Res; 1997 Mar; 57(6):1109-15. PubMed ID: 9067280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner.
    Stewart ZA; Tang LJ; Pietenpol JA
    Oncogene; 2001 Jan; 20(1):113-24. PubMed ID: 11244509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.
    Asnaghi L; Calastretti A; Bevilacqua A; D'Agnano I; Gatti G; Canti G; Delia D; Capaccioli S; Nicolin A
    Oncogene; 2004 Jul; 23(34):5781-91. PubMed ID: 15208671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis.
    Basu A; Haldar S
    FEBS Lett; 2003 Mar; 538(1-3):41-7. PubMed ID: 12633850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Bcl2 phosphorylation by stress response kinase pathway.
    Basu A; You SA; Haldar S
    Int J Oncol; 2000 Mar; 16(3):497-500. PubMed ID: 10675481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway.
    Basu A; Haldar S
    Int J Oncol; 2002 Sep; 21(3):597-601. PubMed ID: 12168105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.